Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jane Wimpfheimer Newburger, M.D.

Co-Author

This page shows the publications co-authored by Jane Newburger and Steven Colan.
Connection Strength

2.577
  1. Donald Charles Fyler: 1924–2011. Cardiol Young. 2011 Oct; 21(5):485-9.
    View in: PubMed
    Score: 0.510
  2. Carotid artery intima-media thickness measurements in the youth: reproducibility and technical considerations. J Am Soc Echocardiogr. 2015 Mar; 28(3):309-16.
    View in: PubMed
    Score: 0.159
  3. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013 Sep 17; 62(12):1114-1121.
    View in: PubMed
    Score: 0.144
  4. Coronary artery dimensions in febrile children without Kawasaki disease. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):239-44.
    View in: PubMed
    Score: 0.140
  5. Diastolic function in children with Kawasaki disease. Int J Cardiol. 2011 May 05; 148(3):309-12.
    View in: PubMed
    Score: 0.112
  6. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation. 1989 Jun; 79(6):1237-46.
    View in: PubMed
    Score: 0.109
  7. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
    View in: PubMed
    Score: 0.093
  8. Recombinant human growth hormone treatment for dilated cardiomyopathy in children. Pediatrics. 2004 Oct; 114(4):e452-8.
    View in: PubMed
    Score: 0.079
  9. Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease. J Am Coll Cardiol. 2021 May 18; 77(19):2382-2394.
    View in: PubMed
    Score: 0.062
  10. Aortic root dilation in Kawasaki disease. Am J Cardiol. 2001 Apr 01; 87(7):919-22.
    View in: PubMed
    Score: 0.062
  11. Myocardial fibrosis in patients with a history of Kawasaki disease. Int J Cardiol Heart Vasc. 2021 Feb; 32:100713.
    View in: PubMed
    Score: 0.061
  12. Exogenous growth hormone: a new therapy for dilated cardiomyopathy. Prog Pediatr Cardiol. 2000 Nov 04; 12(1):125-132.
    View in: PubMed
    Score: 0.060
  13. Technical Performance Score's Association With Arterial Switch Operation Outcomes. Ann Thorac Surg. 2021 04; 111(4):1367-1373.
    View in: PubMed
    Score: 0.058
  14. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000 Feb; 139(2 Pt 1):217-23.
    View in: PubMed
    Score: 0.057
  15. The Pediatric Heart Network Residual Lesion Score Study: Design and objectives. J Thorac Cardiovasc Surg. 2020 07; 160(1):218-223.e1.
    View in: PubMed
    Score: 0.056
  16. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998 Aug; 133(2):254-8.
    View in: PubMed
    Score: 0.051
  17. Implementation of a Quality Improvement Bundle Improves Echocardiographic Imaging after Congenital Heart Surgery in Children. J Am Soc Echocardiogr. 2016 12; 29(12):1163-1170.e3.
    View in: PubMed
    Score: 0.045
  18. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr. 2016 Feb; 29(2):150-7.
    View in: PubMed
    Score: 0.042
  19. Impact of Variability in Echocardiographic Interpretation on Assessment of Adequacy of Repair Following Congenital Heart Surgery: A Pilot Study. Pediatr Cardiol. 2016 Jan; 37(1):144-50.
    View in: PubMed
    Score: 0.042
  20. Left Ventricular Strain and Myocardial Fibrosis in Congenital Aortic Stenosis. Am J Cardiol. 2015 Oct 15; 116(8):1257-62.
    View in: PubMed
    Score: 0.042
  21. Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc. 2014 Jun 23; 3(3):e000079.
    View in: PubMed
    Score: 0.039
  22. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2208-13, 2214.e1-6.
    View in: PubMed
    Score: 0.039
  23. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014 May 06; 63(17):1778-85.
    View in: PubMed
    Score: 0.038
  24. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994 Jan; 89(1):252-7.
    View in: PubMed
    Score: 0.037
  25. Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs). Congenit Heart Dis. 2011 Nov-Dec; 6(6):558-65.
    View in: PubMed
    Score: 0.032
  26. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 06; 324(23):1633-9.
    View in: PubMed
    Score: 0.031
  27. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb; 161(2):233-40.
    View in: PubMed
    Score: 0.030
  28. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011 Jan 04; 57(1):86-92.
    View in: PubMed
    Score: 0.030
  29. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr. 2011 Jan; 24(1):53-9.
    View in: PubMed
    Score: 0.030
  30. Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J. 2011 Jan; 161(1):13-67.
    View in: PubMed
    Score: 0.030
  31. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3.
    View in: PubMed
    Score: 0.030
  32. A novel approach to gathering and acting on relevant clinical information: SCAMPs. Congenit Heart Dis. 2010 Jul-Aug; 5(4):343-53.
    View in: PubMed
    Score: 0.029
  33. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010 Jul-Aug; 5(4):374-81.
    View in: PubMed
    Score: 0.029
  34. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010 May 27; 362(21):1980-92.
    View in: PubMed
    Score: 0.029
  35. Functional state following the Fontan procedure. Cardiol Young. 2009 Aug; 19(4):320-30.
    View in: PubMed
    Score: 0.027
  36. Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr. 2009 Jun; 154(6):901-5.
    View in: PubMed
    Score: 0.027
  37. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):968-75.
    View in: PubMed
    Score: 0.025
  38. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40.
    View in: PubMed
    Score: 0.024
  39. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007 Jul 10; 116(2):174-9.
    View in: PubMed
    Score: 0.024
  40. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg. 1997 Sep; 114(3):392-403; discussion 404-5.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.